From:  Retrospective immunophenotypical evaluation of MET, PD-1/PD-L1, and mTOR pathways in primary tumors and pulmonary metastases of renal cell carcinoma: the RIVELATOR study addresses the issue of biomarkers heterogeneity
 

Qualitative results of the analyzed biomarkers in the study population

BiomarkerPrimary tumorPulmonary metastasis
Number of cases%Number of cases%
MET+23922496
-2814
mTOR +20801976
-520624
4EBP1+228825100
-31200
S6RP +6241872
-1976728
Return to article view

+: positive; -: negative